Fresenius Kidney Care - Niagara is a medicare approved dialysis facility center in Niagara Falls, New York and it has 15 dialysis stations. It is located in Niagara county at 3018 Military Road, Niagara Falls, NY, 14304. You can reach out to the office of Fresenius Kidney Care - Niagara at (716) 298-4195. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fresenius Kidney Care - Niagara has the following ownership type - Profit. It was first certified by medicare in October, 1993. The medicare id for this facility is 332549 and it accepts patients under medicare ESRD program.
| Name | Fresenius Kidney Care - Niagara |
|---|---|
| Location | 3018 Military Road, Niagara Falls, New York |
| No. of Dialysis Stations | 15 |
| Medicare ID | 332549 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | Yes |
| 3018 Military Road, Niagara Falls, New York, 14304 | |
| (716) 298-4195 | |
News Archive
Vocera Communications, Inc., the leading provider of point-of-care communication solutions, today announced two acquisitions: Clinical Health Communications, makers of OptiVox®, and Integrated Voice Solutions, makers of VoiceCare®.
Recently, some scientists have suggested that medical injections with contaminated needles were an important, but ignored, factor in the spread of HIV across sub-Saharan Africa. However, research published today in Public Library of Science Medicine shows that injections with dirty needles are not a major source of HIV transmission in rural Zimbabwe.
A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research.
Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.
AtriCure, Inc., the leader in surgical ablation for the treatment of Atrial Fibrillation, has announced FDA approval of the ABLATE Post Approval Study (PAS).
› Verified 2 days ago
| NPI Number | 1336161066 |
| Organization Name | Niagara Renal Center |
| Doing Business As | Apollo Healthcare Llc |
| Address | 3018 Military Road Niagara Falls, New York, 14304 |
| Phone Number | (716) 298-4195 |
News Archive
Vocera Communications, Inc., the leading provider of point-of-care communication solutions, today announced two acquisitions: Clinical Health Communications, makers of OptiVox®, and Integrated Voice Solutions, makers of VoiceCare®.
Recently, some scientists have suggested that medical injections with contaminated needles were an important, but ignored, factor in the spread of HIV across sub-Saharan Africa. However, research published today in Public Library of Science Medicine shows that injections with dirty needles are not a major source of HIV transmission in rural Zimbabwe.
A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research.
Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.
AtriCure, Inc., the leader in surgical ablation for the treatment of Atrial Fibrillation, has announced FDA approval of the ABLATE Post Approval Study (PAS).
› Verified 2 days ago
| NPI Number | 1508399452 |
| Organization Name | Fresenius Kidney Care - Niagra |
| Doing Business As | New York Dialysis Services, Inc. |
| Address | 3018 Military Rd Niagara Falls, New York, 14304 |
| Phone Number | (716) 298-4195 |
News Archive
Vocera Communications, Inc., the leading provider of point-of-care communication solutions, today announced two acquisitions: Clinical Health Communications, makers of OptiVox®, and Integrated Voice Solutions, makers of VoiceCare®.
Recently, some scientists have suggested that medical injections with contaminated needles were an important, but ignored, factor in the spread of HIV across sub-Saharan Africa. However, research published today in Public Library of Science Medicine shows that injections with dirty needles are not a major source of HIV transmission in rural Zimbabwe.
A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research.
Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.
AtriCure, Inc., the leader in surgical ablation for the treatment of Atrial Fibrillation, has announced FDA approval of the ABLATE Post Approval Study (PAS).
› Verified 2 days ago
| Dialysis patients with Hemoglobin data | 18 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 11 |
News Archive
Vocera Communications, Inc., the leading provider of point-of-care communication solutions, today announced two acquisitions: Clinical Health Communications, makers of OptiVox®, and Integrated Voice Solutions, makers of VoiceCare®.
Recently, some scientists have suggested that medical injections with contaminated needles were an important, but ignored, factor in the spread of HIV across sub-Saharan Africa. However, research published today in Public Library of Science Medicine shows that injections with dirty needles are not a major source of HIV transmission in rural Zimbabwe.
A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research.
Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.
AtriCure, Inc., the leader in surgical ablation for the treatment of Atrial Fibrillation, has announced FDA approval of the ABLATE Post Approval Study (PAS).
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 48 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 394 |
| Percentage of adult patients getting regular hemodialysis at the center | 96 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Vocera Communications, Inc., the leading provider of point-of-care communication solutions, today announced two acquisitions: Clinical Health Communications, makers of OptiVox®, and Integrated Voice Solutions, makers of VoiceCare®.
Recently, some scientists have suggested that medical injections with contaminated needles were an important, but ignored, factor in the spread of HIV across sub-Saharan Africa. However, research published today in Public Library of Science Medicine shows that injections with dirty needles are not a major source of HIV transmission in rural Zimbabwe.
A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research.
Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.
AtriCure, Inc., the leader in surgical ablation for the treatment of Atrial Fibrillation, has announced FDA approval of the ABLATE Post Approval Study (PAS).
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fresenius Kidney Care - Niagara with elevated calcium levels.
| Patients with hypercalcemia | 52 |
| Hypercalcemia patient months | 443 |
| Patients with Serumphosphor | 53 |
| Patients with Serumphosphor less than 3.5 mg/dL | 8 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 24 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 24 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 29 |
| Patients with Serumphosphor greater than 7 mg/dL | 13 |
News Archive
Vocera Communications, Inc., the leading provider of point-of-care communication solutions, today announced two acquisitions: Clinical Health Communications, makers of OptiVox®, and Integrated Voice Solutions, makers of VoiceCare®.
Recently, some scientists have suggested that medical injections with contaminated needles were an important, but ignored, factor in the spread of HIV across sub-Saharan Africa. However, research published today in Public Library of Science Medicine shows that injections with dirty needles are not a major source of HIV transmission in rural Zimbabwe.
A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research.
Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.
AtriCure, Inc., the leader in surgical ablation for the treatment of Atrial Fibrillation, has announced FDA approval of the ABLATE Post Approval Study (PAS).
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 41 |
| Patient months included in arterial venous fistula and catheter summaries | 207 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 85 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 3 |
News Archive
Vocera Communications, Inc., the leading provider of point-of-care communication solutions, today announced two acquisitions: Clinical Health Communications, makers of OptiVox®, and Integrated Voice Solutions, makers of VoiceCare®.
Recently, some scientists have suggested that medical injections with contaminated needles were an important, but ignored, factor in the spread of HIV across sub-Saharan Africa. However, research published today in Public Library of Science Medicine shows that injections with dirty needles are not a major source of HIV transmission in rural Zimbabwe.
A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research.
Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.
AtriCure, Inc., the leader in surgical ablation for the treatment of Atrial Fibrillation, has announced FDA approval of the ABLATE Post Approval Study (PAS).
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 52 |
| Hospitalization Rate in facility | 271.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 453.1 |
| Hospitalization Rate: Lower Confidence Limit | 168.3 |
News Archive
Vocera Communications, Inc., the leading provider of point-of-care communication solutions, today announced two acquisitions: Clinical Health Communications, makers of OptiVox®, and Integrated Voice Solutions, makers of VoiceCare®.
Recently, some scientists have suggested that medical injections with contaminated needles were an important, but ignored, factor in the spread of HIV across sub-Saharan Africa. However, research published today in Public Library of Science Medicine shows that injections with dirty needles are not a major source of HIV transmission in rural Zimbabwe.
A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research.
Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.
AtriCure, Inc., the leader in surgical ablation for the treatment of Atrial Fibrillation, has announced FDA approval of the ABLATE Post Approval Study (PAS).
› Verified 2 days ago
The rate of readmission show you whether patients who were being treated regularly at Fresenius Kidney Care - Niagara were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 38.3 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 53.5 |
| Readmission Rate: Lower Confidence Limit | 25.2 |
News Archive
Vocera Communications, Inc., the leading provider of point-of-care communication solutions, today announced two acquisitions: Clinical Health Communications, makers of OptiVox®, and Integrated Voice Solutions, makers of VoiceCare®.
Recently, some scientists have suggested that medical injections with contaminated needles were an important, but ignored, factor in the spread of HIV across sub-Saharan Africa. However, research published today in Public Library of Science Medicine shows that injections with dirty needles are not a major source of HIV transmission in rural Zimbabwe.
A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research.
Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.
AtriCure, Inc., the leader in surgical ablation for the treatment of Atrial Fibrillation, has announced FDA approval of the ABLATE Post Approval Study (PAS).
› Verified 2 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Fresenius Kidney Care - Niagara get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 3.08 (Worse than Expected) |
| SIR: Upper Confidence Limit | 5.65 |
| SIR: Lower Confidence Limit | 1.5 |
News Archive
Vocera Communications, Inc., the leading provider of point-of-care communication solutions, today announced two acquisitions: Clinical Health Communications, makers of OptiVox®, and Integrated Voice Solutions, makers of VoiceCare®.
Recently, some scientists have suggested that medical injections with contaminated needles were an important, but ignored, factor in the spread of HIV across sub-Saharan Africa. However, research published today in Public Library of Science Medicine shows that injections with dirty needles are not a major source of HIV transmission in rural Zimbabwe.
A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research.
Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.
AtriCure, Inc., the leader in surgical ablation for the treatment of Atrial Fibrillation, has announced FDA approval of the ABLATE Post Approval Study (PAS).
› Verified 2 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fresenius Kidney Care - Niagara's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 42 |
| Transfusion Rate in facility | 86.4 (Worse than Expected) |
| Transfusion Rate: Upper Confidence Limit | 209 |
| Transfusion Rate: Lower Confidence Limit | 39.8 |
News Archive
Vocera Communications, Inc., the leading provider of point-of-care communication solutions, today announced two acquisitions: Clinical Health Communications, makers of OptiVox®, and Integrated Voice Solutions, makers of VoiceCare®.
Recently, some scientists have suggested that medical injections with contaminated needles were an important, but ignored, factor in the spread of HIV across sub-Saharan Africa. However, research published today in Public Library of Science Medicine shows that injections with dirty needles are not a major source of HIV transmission in rural Zimbabwe.
A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research.
Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.
AtriCure, Inc., the leader in surgical ablation for the treatment of Atrial Fibrillation, has announced FDA approval of the ABLATE Post Approval Study (PAS).
› Verified 2 days ago
The rate of mortality show you whether patients who were being treated regularly at Fresenius Kidney Care - Niagara lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 301 |
| Mortality Rate in facility | 16.1 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 21.4 |
| Mortality Rate: Lower Confidence Limit | 11.8 |
News Archive
Vocera Communications, Inc., the leading provider of point-of-care communication solutions, today announced two acquisitions: Clinical Health Communications, makers of OptiVox®, and Integrated Voice Solutions, makers of VoiceCare®.
Recently, some scientists have suggested that medical injections with contaminated needles were an important, but ignored, factor in the spread of HIV across sub-Saharan Africa. However, research published today in Public Library of Science Medicine shows that injections with dirty needles are not a major source of HIV transmission in rural Zimbabwe.
A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research.
Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.
AtriCure, Inc., the leader in surgical ablation for the treatment of Atrial Fibrillation, has announced FDA approval of the ABLATE Post Approval Study (PAS).
› Verified 2 days ago
Fresenius Kidney Care - Niagara Location: 3018 Military Road, Niagara Falls, New York, 14304 Phone: (716) 298-4195 |
Niagara Falls Kidney Care Center Location: 621 10th Street, Niagara Falls, New York, 14301 Phone: (716) 278-4639 |
Niagara Dialysis Center Location: 2932 Military Road, Niagara Falls, New York, 14304 Phone: (716) 297-4059 |
News Archive
Vocera Communications, Inc., the leading provider of point-of-care communication solutions, today announced two acquisitions: Clinical Health Communications, makers of OptiVox®, and Integrated Voice Solutions, makers of VoiceCare®.
Recently, some scientists have suggested that medical injections with contaminated needles were an important, but ignored, factor in the spread of HIV across sub-Saharan Africa. However, research published today in Public Library of Science Medicine shows that injections with dirty needles are not a major source of HIV transmission in rural Zimbabwe.
A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research.
Responding to a request from a Chinese biotechnology company working closely with officials in China, Medarex, Inc. and the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) have shipped to Beijing a sample of the fully human antibody to SARS developed by Medarex and MBL/UMMS.
AtriCure, Inc., the leader in surgical ablation for the treatment of Atrial Fibrillation, has announced FDA approval of the ABLATE Post Approval Study (PAS).
› Verified 2 days ago